| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | N-acetylmuramoyl-L-alanine amidase activity | 7.87e-05 | 4 | 73 | 2 | GO:0008745 | |
| GeneOntologyMolecularFunction | peptidoglycan immune receptor activity | 1.31e-04 | 5 | 73 | 2 | GO:0016019 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell differentiation | 7.18e-05 | 4 | 72 | 2 | GO:0032824 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell differentiation involved in immune response | 7.18e-05 | 4 | 72 | 2 | GO:0032827 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 1.10e-04 | 422 | 72 | 8 | GO:1990778 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation involved in immune response | 1.19e-04 | 5 | 72 | 2 | GO:0002325 | |
| GeneOntologyBiologicalProcess | protein localization to paranode region of axon | 1.19e-04 | 5 | 72 | 2 | GO:0002175 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation involved in immune response | 1.19e-04 | 5 | 72 | 2 | GO:0032826 | |
| GeneOntologyBiologicalProcess | peptidoglycan catabolic process | 1.79e-04 | 6 | 72 | 2 | GO:0009253 | |
| GeneOntologyBiologicalProcess | peptidoglycan metabolic process | 1.79e-04 | 6 | 72 | 2 | GO:0000270 | |
| GeneOntologyBiologicalProcess | axon ensheathment in central nervous system | 2.06e-04 | 33 | 72 | 3 | GO:0032291 | |
| GeneOntologyBiologicalProcess | central nervous system myelination | 2.06e-04 | 33 | 72 | 3 | GO:0022010 | |
| MousePheno | intestinal ulcer | 3.27e-06 | 24 | 61 | 4 | MP:0000512 | |
| MousePheno | gastrointestinal ulcer | 9.45e-06 | 31 | 61 | 4 | MP:0003300 | |
| Domain | DVL-1 | 1.55e-05 | 2 | 74 | 2 | IPR008340 | |
| Domain | Amidase_domain | 9.24e-05 | 4 | 74 | 2 | IPR002502 | |
| Domain | Ami_2 | 9.24e-05 | 4 | 74 | 2 | SM00644 | |
| Domain | - | 9.24e-05 | 4 | 74 | 2 | 3.40.80.10 | |
| Domain | PGRP | 9.24e-05 | 4 | 74 | 2 | SM00701 | |
| Domain | Dishevelled_fam | 9.24e-05 | 4 | 74 | 2 | IPR008339 | |
| Domain | Amidase_2 | 9.24e-05 | 4 | 74 | 2 | PF01510 | |
| Domain | Dishevelled | 9.24e-05 | 4 | 74 | 2 | PF02377 | |
| Domain | Dishevelled_protein_dom | 9.24e-05 | 4 | 74 | 2 | IPR003351 | |
| Domain | PGRP_domain_met/bac | 9.24e-05 | 4 | 74 | 2 | IPR006619 | |
| Domain | PGRP | 9.24e-05 | 4 | 74 | 2 | IPR015510 | |
| Domain | DIX | 3.21e-04 | 7 | 74 | 2 | PF00778 | |
| Domain | DIX | 3.21e-04 | 7 | 74 | 2 | IPR001158 | |
| Domain | DIX | 3.21e-04 | 7 | 74 | 2 | PS50841 | |
| Domain | DAX | 3.21e-04 | 7 | 74 | 2 | SM00021 | |
| Pubmed | 3.57e-06 | 415 | 76 | 8 | 16385451 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16362825 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 15177568 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 8644734 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24063864 | ||
| Pubmed | Peptidoglycan recognition proteins are a new class of human bactericidal proteins. | 1.41e-05 | 3 | 76 | 2 | 16354652 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 26039076 | ||
| Pubmed | Cot/tpl2 participates in the activation of macrophages by adiponectin. | 1.41e-05 | 3 | 76 | 2 | 24532642 | |
| Pubmed | Structural insights into the bactericidal mechanism of human peptidoglycan recognition proteins. | 1.41e-05 | 3 | 76 | 2 | 17502600 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 26332373 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 33689679 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 8817329 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 20709292 | ||
| Pubmed | A case-by-case evolutionary analysis of four imprinted retrogenes. | 2.82e-05 | 4 | 76 | 2 | 21166792 | |
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 2.82e-05 | 4 | 76 | 2 | 9192851 | |
| Pubmed | Non-canonical Wnt signaling induces ubiquitination and degradation of Syndecan4. | 2.82e-05 | 4 | 76 | 2 | 20639201 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 26727498 | ||
| Pubmed | Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. | 2.82e-05 | 4 | 76 | 2 | 19414798 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 11461926 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 21949809 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 22048773 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | PDXDC1 ADIPOQ P3H3 TM9SF3 CNTNAP1 LRP1 FADS2 LOXL4 RARS2 PNPLA7 CSGALNACT1 ADPGK | 6.96e-05 | 1451 | 76 | 12 | 30550785 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 8.32e-05 | 202 | 76 | 5 | 33005030 | |
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 35253879 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 17291163 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 19643732 | ||
| Pubmed | PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation. | 1.31e-04 | 8 | 76 | 2 | 19218085 | |
| Pubmed | 3.44e-04 | 1006 | 76 | 9 | 15226823 | ||
| Pubmed | 4.22e-04 | 14 | 76 | 2 | 21795692 | ||
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 4.38e-04 | 161 | 76 | 4 | 32572027 | |
| Pubmed | PDXDC1 TARDBP MISP P3H3 PREP CNTNAP1 KDM3B MMS19 ARHGEF17 ADPGK | 5.13e-04 | 1297 | 76 | 10 | 33545068 | |
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 5.41e-04 | 303 | 76 | 5 | 25056061 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 6.13e-04 | 475 | 76 | 6 | 31040226 | |
| Pubmed | 7.87e-04 | 19 | 76 | 2 | 16697675 | ||
| Pubmed | 7.87e-04 | 19 | 76 | 2 | 34988124 | ||
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | 9.32e-04 | 342 | 76 | 5 | 23455924 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.20e-03 | 211 | 76 | 4 | 24097068 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPTX1 P3H3 TM9SF3 CNTNAP1 LRP1 FADS2 RXYLT1 CSGALNACT1 ADPGK | 1.21e-03 | 1201 | 76 | 9 | 35696571 |
| Pubmed | 1.26e-03 | 24 | 76 | 2 | 18425126 | ||
| Pubmed | 1.39e-03 | 985 | 76 | 8 | 12975309 | ||
| Pubmed | Developmental gene expression profiling along the tonotopic axis of the mouse cochlea. | 1.72e-03 | 28 | 76 | 2 | 22808246 | |
| Pubmed | 1.84e-03 | 29 | 76 | 2 | 21829377 | ||
| Pubmed | Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function. | 1.97e-03 | 30 | 76 | 2 | 27568567 | |
| Pubmed | 1.97e-03 | 30 | 76 | 2 | 19077438 | ||
| Cytoband | 1q21 | 4.96e-04 | 91 | 77 | 3 | 1q21 | |
| Cytoband | 19p13.3 | 6.97e-04 | 237 | 77 | 4 | 19p13.3 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | ZNF276 CFAP52 MCTS1 CNTNAP1 PCDHB13 LRP1 TBC1D22B GMPPA CTSO | 6.05e-06 | 449 | 76 | 9 | M2013 |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | ZNF276 CFAP52 MCTS1 CNTNAP1 PCDHB13 LRP1 TBC1D22B GMPPA CTSO | 1.36e-05 | 497 | 76 | 9 | MM863 |
| Disease | 1-oleoyl-2-dihomo-linolenoyl-GPC (18:1/20:3) measurement | 1.86e-05 | 3 | 74 | 2 | EFO_0800461 | |
| Disease | 1-dihomo-linolenoyl-GPC (20:3n3 or 6) measurement | 3.71e-05 | 4 | 74 | 2 | EFO_0800235 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 6.17e-05 | 5 | 74 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | 1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) measurement | 6.17e-05 | 5 | 74 | 2 | EFO_0800407 | |
| Disease | dihomo-linolenate 20:3n3 or n6 measurement | 9.25e-05 | 6 | 74 | 2 | EFO_0021046 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4n6) measurement | 9.25e-05 | 6 | 74 | 2 | EFO_0800390 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6) measurement | 9.25e-05 | 6 | 74 | 2 | EFO_0800434 | |
| Disease | 1-dihomo-linolenoyl-GPE (20:3n3 or 6) measurement | 9.25e-05 | 6 | 74 | 2 | EFO_0800358 | |
| Disease | Toxoplasma gondii seropositivity | 1.29e-04 | 7 | 74 | 2 | EFO_0007047 | |
| Disease | fatty acid desaturase enzyme activity measurement | 1.72e-04 | 8 | 74 | 2 | EFO_0009791 | |
| Disease | blindness (implicated_via_orthology) | 1.72e-04 | 8 | 74 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 2.21e-04 | 9 | 74 | 2 | OBA_2045130 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) measurement | 2.21e-04 | 9 | 74 | 2 | EFO_0800271 | |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 2.76e-04 | 10 | 74 | 2 | OBA_2045075 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 4.03e-04 | 12 | 74 | 2 | OBA_2045152 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:3) in blood serum | 4.03e-04 | 12 | 74 | 2 | OBA_2045115 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 4.03e-04 | 12 | 74 | 2 | OBA_2045157 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 4.75e-04 | 13 | 74 | 2 | EFO_0800547 | |
| Disease | phosphatidylcholine 40:7 measurement | 4.75e-04 | 13 | 74 | 2 | EFO_0021477 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.93e-04 | 145 | 74 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 5.54e-04 | 14 | 74 | 2 | EFO_0022085 | |
| Disease | proliferative diabetic retinopathy (is_marker_for) | 7.28e-04 | 16 | 74 | 2 | DOID:13207 (is_marker_for) | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 7.28e-04 | 16 | 74 | 2 | OBA_2045093 | |
| Disease | metabolite measurement, diet measurement | 7.66e-04 | 71 | 74 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | triacylglycerol 56:3 measurement | 9.25e-04 | 18 | 74 | 2 | EFO_0010430 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 9.25e-04 | 18 | 74 | 2 | OBA_2045065 | |
| Disease | Manic | 1.01e-03 | 78 | 74 | 3 | C0338831 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 1.03e-03 | 19 | 74 | 2 | OBA_2045199 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 1.14e-03 | 20 | 74 | 2 | OBA_2045071 | |
| Disease | coronary atherosclerosis measurement, traffic air pollution measurement | 1.26e-03 | 21 | 74 | 2 | EFO_0007908, EFO_0007938 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.78e-03 | 95 | 74 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | alpha-linolenic acid measurement | 1.79e-03 | 25 | 74 | 2 | EFO_0007759 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.83e-03 | 96 | 74 | 3 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | phosphatidylcholine 38:4 measurement | 2.25e-03 | 28 | 74 | 2 | EFO_0010386 | |
| Disease | level of Phosphatidylethanolamine (18:0_18:2) in blood serum | 2.25e-03 | 28 | 74 | 2 | OBA_2045139 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.43e-03 | 106 | 74 | 3 | EFO_0008317, EFO_0008596 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EWGVYTIIEDLHGAG | 1096 | Q5DID0 | |
| FHLILEYQAGEEWGQ | 206 | Q9BRR6 | |
| YHDEGWVAILLGFLV | 1276 | P78357 | |
| DYLDWEVGVHGIRIE | 206 | Q6DCA0 | |
| LYIAWAGHLEAQGEL | 101 | O43683 | |
| LWLYGEDHQITEVGT | 246 | P54687 | |
| LDIKGWGGEDVHLYR | 441 | Q8TDX6 | |
| EVGDQVWLQVYGEGE | 206 | Q15848 | |
| DAEGHLIYHVGDWLQ | 146 | P49760 | |
| WLYEQIEIEGGEIIH | 241 | Q8N8R7 | |
| WVNGVDTVEHEGGYL | 136 | Q6P575 | |
| IDYTVLDDVGHGVKW | 141 | Q8IZP0 | |
| YGLEHWGSDTQGVEK | 556 | Q96G46 | |
| YLDVGWGLGSVTHEL | 371 | P19801 | |
| AGRVEIYHDGFWGTI | 1046 | Q9NR16 | |
| LHGHWGLGQVVTDYV | 101 | O14521 | |
| LNGEGHVFVWGYGIL | 351 | Q96I51 | |
| QGGLYEAIAGHWIQV | 276 | Q8IVL6 | |
| VIAWAESHIEIYGGA | 406 | Q15818 | |
| GELVVYQREAGHFWD | 1791 | Q96PE2 | |
| LHVFVLGEWQPIEYG | 236 | O95864 | |
| GLHSENREDEGWQVY | 81 | Q8IVT2 | |
| ELGLFGVWAHNGEVR | 611 | Q9Y5F0 | |
| EGAVEVKYEGHWRQV | 176 | Q96JB6 | |
| GIGIENIHYLNDGLW | 161 | Q9ULC4 | |
| GIGIENIHYLNDGLW | 161 | A0A3B3IRV3 | |
| GVYDGEEHSVFGEPW | 231 | O15479 | |
| LFGVVWYLVAVAHGD | 81 | P78508 | |
| GVQWAELAGHDYVLD | 2271 | Q9UKN7 | |
| LWGLVHDFVVGQQEG | 16 | Q96T76 | |
| LGDTLIDGGEHYWEV | 346 | Q9BTV5 | |
| NVGSVEGLAYHRGWD | 2281 | Q07954 | |
| VQEYVVEWRELHPGG | 451 | Q99665 | |
| VWDYNEGEVTHVGVG | 571 | Q8N1V2 | |
| RHENIAELYGAVLWG | 186 | P41279 | |
| AELYGAVLWGETVHL | 191 | P41279 | |
| IVGGGCLVLEYWRHQ | 91 | Q9H6K4 | |
| VGQDGGVYEGVGWHI | 246 | Q96LB9 | |
| RVYEGVGWNIQGVHT | 126 | Q96LB8 | |
| EQYGIWLHVEGVNLA | 261 | Q6P996 | |
| EQYGIWLHVEGVNLA | 261 | Q6P474 | |
| EEGWLYGVVSHQDSI | 211 | Q7LBC6 | |
| AGAVDVVRHWQDLGY | 1131 | Q9BZ72 | |
| EVGYQHGRTVFDIWG | 1191 | Q6ZV29 | |
| YGDVIGLQVDYWLGH | 816 | Q6VY07 | |
| VANIRGGGEYGETWH | 501 | P48147 | |
| AGQGQIYVHLTDGIW | 231 | Q96IJ6 | |
| HVGEEEEDTNLWIGY | 51 | A0AVF1 | |
| QIGDTVHILETYEGW | 31 | Q14185 | |
| EQWEVRHGGLLGIKY | 401 | O14981 | |
| IHYGIIDNDGGWVDI | 341 | Q9H336 | |
| RDGWIVDYIHIFGQG | 76 | A8MV24 | |
| IWHYPGEEVNAGRIG | 336 | Q9UPI3 | |
| GEVVLPAWYTLHGEV | 46 | Q96AP7 | |
| ILYIIGAHGGETSWV | 71 | P21145 | |
| GYIVLGLVAWVHGDP | 51 | Q8NCS7 | |
| IGADVVDWLYTHVEG | 446 | O14640 | |
| IGADVVDWLYTHVEG | 421 | P54792 | |
| HVIAWQQGEYGEFVI | 56 | Q6ZN32 | |
| HVGTWHEGVLNIDDY | 496 | Q13255 | |
| AAIGLYLWEHIFEGL | 106 | Q9Y2B1 | |
| TIEGEWFYGPVDLHV | 2351 | Q6ZTR5 | |
| LGHQVIRINYLGDWG | 161 | Q5T160 | |
| HWGNEEIGLLLAEAY | 476 | Q9NU19 | |
| LHAPDAGWGNLVYVV | 61 | Q13148 | |
| EVVEVGHFWGYRIDE | 906 | Q8NDG6 | |
| WGYCLTQVVGGHLGD | 71 | Q9BYT1 | |
| DAVSWQDYLGGIIQH | 246 | P43234 | |
| EAADVWYNLGHVAVG | 421 | Q8TAM2 | |
| GAHIIVTPEDAIYGW | 71 | O95497 | |
| DGEDLAGQPWYHGLL | 6 | Q9BRG2 | |
| GWNTYLVDGHDVEAL | 211 | Q9H0I9 | |
| GVIQVVWGCDQGHDY | 226 | Q8N554 | |
| EAEGELSEGEHWYGN | 21 | Q17R98 | |
| RDLGDEYGWKQVHGD | 266 | Q9HD45 | |
| GGVYPEVLFEVAHQW | 1406 | A7E2V4 | |
| AQIWLHAAEVYIGIG | 696 | Q86TV6 | |
| EHGVWLIGLKEGRVY | 381 | Q86XT4 | |
| VGEGAYRWAVDHGIP | 166 | Q9H6P5 | |
| HYWEVLVGEGAEWGL | 346 | Q8NG06 |